Suppr超能文献

干细胞样癌细胞的侵袭体:转移机制与可靶向的脆弱性

The invadosome of stem-like cancer cells: metastasis machinery and targetable vulnerability.

作者信息

Tsai Kelvin K

机构信息

Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei City, 110301, Taiwan.

TMU Core Laboratory of Organoids Technology (TCLOT), Taipei Medical University, Taipei City, 110301, Taiwan.

出版信息

Cancer Metastasis Rev. 2025 Jun 4;44(2):53. doi: 10.1007/s10555-025-10270-6.

Abstract

Despite recent advances in targeted and immuno-therapy, metastasis still kills most cancer patients. Overcoming cancer metastasis requires a leap forward in understanding its molecular underpinnings to identify breakthrough therapeutic targets and strategies. A growing body of evidence suggests that specific subsets of cancer cells, which exhibit stem-like properties and are referred to as cancer stem cells (CSCs), are the primary drivers of cancer metastasis. How CSCs contribute to the multistep process of invasion and metastasis remains incompletely understood. Invadosomes are dynamic actin-based cellular protrusions that mediate cell invasion and pericellular proteolysis. Recent data have highlighted the highly proficient ability of CSCs to generate invadosomes, facilitating their local invasiveness, intravasation, extravasation, and metastatic colonization. This up-to-date and focused review describes the recent progress in characterizing invadosomes in embryonic cells during development and in CSCs during cancer metastasis. We summarize the molecular processes that regulate the invadosomes of CSCs. We discuss the molecules associated with the invadosome of CSCs and highlight their correlation with cancer metastasis in patients. We propose targeting the invadosomes of CSCs as a novel strategy to overcome cancer invasiveness and metastasis. This review highlights the emerging role of invadosomes in CSCs and provides a new perspective on pathobiology and cancer metastasis treatment.

摘要

尽管在靶向治疗和免疫治疗方面取得了最新进展,但转移仍然导致大多数癌症患者死亡。要克服癌症转移,需要在理解其分子基础方面取得重大突破,以确定突破性的治疗靶点和策略。越来越多的证据表明,具有干细胞样特性的特定癌细胞亚群,即所谓的癌症干细胞(CSCs),是癌症转移的主要驱动因素。癌症干细胞如何促成侵袭和转移的多步骤过程仍未完全了解。侵袭性伪足是基于肌动蛋白的动态细胞突起,介导细胞侵袭和细胞周围蛋白水解。最近的数据突出了癌症干细胞产生侵袭性伪足的高度熟练能力,促进了它们的局部侵袭、血管内侵入、血管外渗和转移定植。这篇最新的重点综述描述了在发育过程中胚胎细胞以及癌症转移过程中癌症干细胞侵袭性伪足特征研究的最新进展。我们总结了调节癌症干细胞侵袭性伪足的分子过程。我们讨论了与癌症干细胞侵袭性伪足相关的分子,并强调了它们与癌症患者转移的相关性。我们提出将靶向癌症干细胞的侵袭性伪足作为克服癌症侵袭和转移的新策略。这篇综述突出了侵袭性伪足在癌症干细胞中的新作用,并为病理生物学和癌症转移治疗提供了新的视角。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验